Home Healthcare Medical Devices Anti-Snoring Devices Market

Anti-Snoring Devices Market Size, Share & Trends Analysis Report By Product Type (Oral Appliances, Nasal Devices, Continuous Positive Airway Pressure (CPAP) Devices, Chin Straps, Position Control Devices, Smart Anti-Snoring Devices, Others (e.g., Anti-Snoring Pillows)), By Distribution Channel (Online Retail, Hospital Pharmacies, Retail Pharmacies, Clinics, Others (e.g., Specialty Stores)), By End User (Homecare, Hospitals, Sleep Clinics, Others (e.g., Research Institutes)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Anti-Snoring Devices Market Size

The global anti-snoring devices market size was valued at USD 1.22 billion in 2025 and is projected to grow from USD 1.33 billion in 2026 to USD 2.69 billion by 2034, registering a CAGR of 9.19% during the forecast period from 2026 to 2034. North America dominated the anti-snoring devices market with a market share of 38.4% in 2025.

The global anti-snoring devices market is witnessing robust growth, driven by the increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA), and rising awareness of snoring-related health risks, such as cardiovascular issues and sleep deprivation. The growing obese and ageing populations and technological advancements in non-invasive devices like mandibular advancement devices (MADs) and nasal dilators drive market growth. Trends such as smart anti-snoring devices with sensors and AI integration are gaining traction, enhancing user comfort and compliance.

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising disposable incomes and healthcare investments. The market faces challenges like high device costs and limited awareness in low-income areas, but it is supported by innovations and e-commerce accessibility. Strategic partnerships and product launches by key players further propel growth, addressing the needs of millions affected by snoring globally.

Anti-Snoring Devices Market Size

Download a Free Sample To learn more about this report.

Product Type Insights

Oral appliances, particularly mandibular advancement devices (MADs), dominate the market, holding a 38% revenue share in 2024. These oral appliances reposition the lower jaw to keep the airway open, offering a non-invasive and effective solution for mild to moderate obstructive sleep apnea (OSA). The increasing awareness of snoring’s link to serious health risks such as heart disease and stroke further supports market growth. Favourable insurance reimbursement policies, especially in North America, support adoption. Furthermore, the growing ageing population and obesity epidemic increase demand for custom-fit MADs, often made using 3D printing. With rising interest in home-based and wearable health tech, MADs continue to dominate the product segment of this growing market.

Anti-Snoring Devices Market Size By Segments

Request Customizationto receive a tailored report.

Distribution Channel Insights

Online retail leads the distribution channel segment with a 42% share in 2024, driven by the ease of direct-to-consumer (DTC) shopping and a growing preference for e-commerce. With smartphone penetration and digital health platforms expanding, consumers increasingly turn to online channels for FDA-cleared, home-delivered anti-snoring devices. Online stores also offer competitive discounts, subscription models, and access to customer reviews, especially appealing to tech-savvy users in North America and Europe. Awareness campaigns and influencer marketing help build trust, while home delivery and return options further simplify the buying process. The online segment benefits especially from the rising popularity of smart anti-snoring devices, allowing users to purchase tailored solutions without medical visits and supporting market expansion.

End User Insights

The homecare segment dominates the end-user landscape, capturing 55% of the market in 2024, due to the increasing demand for non-invasive, self-managed snoring solutions. Many prefer managing snoring and mild sleep apnea from home using mandibular devices, nasal dilators, or wearable smart tech. As healthcare costs rise globally, homecare devices offer cost-effective alternatives to clinical treatments like CPAP. Ageing populations and higher awareness of snoring’s health impacts contribute to demand. In developed regions, especially the U.S. and Europe, the trend is also supported by reimbursement programs and the desire for privacy and convenience in managing sleep disorders, making home care the fastest expanding end-user segment.

Anti-Snoring Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America leads the anti-snoring devices market due to its advanced healthcare infrastructure and widespread awareness of sleep-related disorders. The region benefits from strong public and private investment in sleep research and innovation, along with the presence of major market players consistently launching technologically advanced solutions. Consumer demand for non-invasive, home-based treatments is growing, driven by rising health consciousness and telemedicine adoption. Supportive reimbursement policies, public education campaigns, and high healthcare accessibility further encourage the use of anti-snoring devices. Additionally, the prevalence of lifestyle-related conditions and an ageing population contribute to increased demand for personalised and easy-to-use sleep aids, reinforcing the region’s dominance in the market.

The U.S. marketis driven by widespread awareness of sleep disorders and a well-established healthcare infrastructure. Rising rates of obesity and ageing are contributing to increased cases of snoring and obstructive sleep apnea, which, in turn, drive demand for non-invasive solutions like oral appliances. Government funding supports innovation and research in sleep health, while private companies continue launching advanced, tech-enabled devices. Additionally, e-commerce platforms make it easier for consumers to access devices directly, while leading players continually expand their product lines to meet evolving consumer needs.

Canada’s anti-snoring devices industry is expanding due to greater public education around sleep health and growing demand for user-friendly home care solutions. Increased healthcare investments support the distribution and accessibility of treatment devices, particularly for sleep apnea. Innovations in device design, especially around comfort and ease of use, are helping attract first-time users. The adoption of telehealth and remote diagnostics supports home-based treatment. Online retail and urban-focused health infrastructure are also improving product accessibility and contributing to consistent market growth.

North America Anti-Snoring Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Anti-Snoring Devices Market

Asia-Pacific is the fastest-growing region in the market, propelled by economic development, rising healthcare awareness, and improving access to medical technologies. Urbanisation and sedentary lifestyles have led to a growing burden of sleep disorders, fueling the need for effective snoring management solutions. Consumers increasingly seek affordable, convenient devices that can be used at home without medical supervision. Growth in e-commerce platforms has made these products more accessible across urban and semi-urban areas. Government-led health campaigns and increased healthcare spending encourage the use of non-invasive therapies. Innovation from regional manufacturers is also expanding the availability of customised and multi-functional devices, making the region highly dynamic and promising for future expansion.

China’s anti-snoring device market is rapidly growing due to increasing urbanisation, healthcare spending, and awareness of sleep disorders. A growing middle class with higher disposable income is driving demand for modern, non-invasive treatments. Government investments in sleep health programs promote awareness and facilitate access to devices. With the popularity of e-commerce platforms, companies can directly reach large customer bases across major cities and emerging regions. Additionally, lifestyle changes contributing to obesity and poor sleep hygiene are increasing the need for effective anti-snoring solutions.

India’s market growth is driven by expanding healthcare infrastructure, rising public awareness of sleep apnea, and increasing investment in sleep-related diagnostics and treatments. Urban populations are embracing advanced oral appliances and nasal devices, supported by targeted health campaigns. The rise of e-commerce platforms is improving access, especially among young professionals seeking affordable and convenient options. Domestic manufacturers are launching cost-effective products to address both snoring and lifestyle-related disorders. Supportive government policies and income growth further enhance market potential.

Europe Anti-Snoring Devices Market

Europe’s growth in the market for anti-snoring devices is driven by a strong focus on preventive healthcare, early diagnosis, and high consumer awareness of sleep health. The region benefits from robust healthcare infrastructure, public insurance systems, and an ageing population increasingly seeking non-invasive snoring solutions. Leading European companies continue to introduce advanced oral and wearable devices, supported by strong medical research and development investments. Public health initiatives encourage better sleep hygiene, while established distribution channels, including pharmacies and online platforms, improve device accessibility. Additionally, rising consumer interest in home-based treatments and comfort-oriented technologies fosters the adoption of customisable, easy-to-use products across the region.

Germany’s anti-snoring devices market benefits from a highly developed healthcare system, strong government support for medical research, and a population prioritising health and wellness. The country has a solid foundation for diagnosing and treating sleep-related disorders, encouraging the use of advanced solutions like mandibular advancement devices and smart wearables. Companies leverage Germany’s medical infrastructure to distribute personalised and comfortable devices. With increased public and private investment in sleep health and growing interest in home care solutions, demand for non-invasive snoring treatments continues to rise steadily.

France’s market is driven by government-backed innovation in medical technology, rising awareness of sleep disorders, and growing consumer demand for non-invasive treatments. Healthcare initiatives and strategic partnerships between manufacturers and local clinics have improved access to advanced oral appliances. Consumers increasingly favour home-use devices such as nasal dilators and smart sensors. Health campaigns and educational efforts from professional associations further boost awareness. The country's commitment to supporting digital health and expanding e-commerce enhances the visibility and distribution of anti-snoring devices.

Company Market Share

Key players in the anti-snoring devices market focus on innovation, launching smart, non-invasive devices like MADs and CPAP machines with AI and Bluetooth connectivity. Strategic partnerships with healthcare providers and e-commerce platforms expand reach. Companies invest in R&D to improve comfort and efficacy, targeting homecare users. Acquisitions and regional expansions, particularly in Asia-Pacific, enhance market share. Sustainability and regulatory compliance are priorities, with firms developing compact, user-friendly solutions to meet growing demand.

ResMed: ResMed is a market leader, leveraging its expertise in sleep apnea solutions to dominate the anti-snoring devices market. The company focuses on innovative CPAP devices and oral appliances, integrating smart connectivity for real-time monitoring. Strategic collaborations with healthcare providers and global distribution networks drive its 20% market share in 2024. ResMed’s R&D investments, targeting compact and user-friendly designs, fuel growth, with a projected 10% revenue increase by 2033. Its focus on homecare solutions aligns with consumer trends, enhancing adoption.

List of Key and Emerging Players in Anti-Snoring Devices Market

ResMed
Koninklijke Philips N.V.
SomnoMed
Fisher & Paykel Healthcare
Glidewell
ZQuiet
SnoreLessNow
Apnea Sciences
VVFLY Electronics
Illusion Aligners
Airway Management
Theravent
Rhinomed
Smart Nora
DeVilbiss Healthcare

Key Industry Developments

April 2026
ResMed expanded its sleep health portfolio by introducing AI-enabled anti-snoring and sleep monitoring solutions designed to improve home-based management of snoring and mild sleep-disordered breathing.
February 2026
Apnea Sciences Corporation launched next-generation mandibular advancement devices featuring enhanced customization and digital fitting technology for improved patient comfort and treatment outcomes.
October 2025
SomnoMed Ltd. expanded its oral appliance portfolio with advanced anti-snoring devices incorporating precision adjustment mechanisms and digital treatment planning capabilities.
June 2025
Nyxoah SA expanded commercialization initiatives supporting its sleep-disordered breathing solutions through new clinical collaborations and market expansion activities.

Report Scope

Segmentation

By Product Type 7
  • Oral Appliances
  • Nasal Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Chin Straps
  • Position Control Devices
  • Smart Anti-Snoring Devices
  • Others (e.g., Anti-Snoring Pillows)
By Distribution Channel 5
  • Online Retail
  • Hospital Pharmacies
  • Retail Pharmacies
  • Clinics
  • Others (e.g., Specialty Stores)
By End User 4
  • Homecare
  • Hospitals
  • Sleep Clinics
  • Others (e.g., Research Institutes)

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage ResMed · Koninklijke Philips N.V. · SomnoMed · Fisher & Paykel Healthcare · Glidewell
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The anti-snoring devices market size is valued at USD 1.33 Billion in 2026 and is projected to reach USD 2.69 Billion by 2034, at a CAGR of 9.19% during the forecast period 2026-2034.

North America dominated the market with a share of 38.4% in 2025.

The leading players in this market are ResMed, Koninklijke Philips N.V., SomnoMed, Fisher & Paykel Healthcare, Glidewell.

The anti-snoring devices market is projected to grow at a CAGR of 9.19% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: